Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Cochrane database of systematic reviews (Online)

Volumn 3, Issue , 2006, Pages

  Appleton, S ^a   Jones, T ^a   Poole, P ^a   Pilotto, L ^a   Adams, R ^a   Lasserson, T J ^a   Smith, B ^a   Muhammad, J ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; DRUG DERIVATIVE; ETHANOLAMINE DERIVATIVE; FORMOTEROL; IPRATROPIUM BROMIDE; SALBUTAMOL; SALMETEROL;

ADULT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BRONCHODILATOR AGENTS; ETHANOLAMINES; HUMANS; IPRATROPIUM; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS;

EID: 33750130578     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (60)